Overview

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of golimumab, alone or in combination with methotrexate, as compared to methotrexate alone in rheumatoid arthritis subjects who have not been previously treated with methotrexate.
Phase:
Phase 3
Details
Lead Sponsor:
Centocor, Inc.
Collaborator:
Schering-Plough
Treatments:
Antibodies, Monoclonal
Golimumab
Methotrexate